Incyte (INCY) Other financing activities (2014 - 2022)
Incyte (INCY) reported Other financing activities of $14.2 million for Q1 2022, down 28.91% on a YoY basis from $20.0 million in Q1 2021, and up 218.72% quarter-over-quarter from -$12.0 million in Q3 2021.
Incyte (INCY) Other financing activities (2014 - 2022) Analysis & Trends
Incyte has reported Other financing activities for 9 years, with the latest figure at $14.2 million in Q1 2022.
- For the quarter ending Q1 2022, Other financing activities fell 28.91% year-over-year to $14.2 million; the trailing twelve-month figure through Mar 2022 stood at $30.1 million (down 34.0% YoY), and the FY2017 full-year result was -$39000.0, down 100.28% from the prior year.
- Other financing activities for Q1 2022 stood at $14.2 million, up from -$12.0 million in the prior quarter.
- The five-year high for Other financing activities was $20.0 million in Q1 2021, with the low at -$12.0 million in Q3 2021.
- Historically, Other financing activities has averaged $9.7 million across 5 years, with a median of $14.4 million in 2020.
- Annual changes were most pronounced in 2018 — Other financing activities jumped 37856.1% — and 2021, when it slumped 254.08%.
- Incyte's Other financing activities stood at $15.5 million in 2018, then tumbled by 79.9% to $3.1 million in 2019, then surged by 150.18% to $7.8 million in 2020, then tumbled by 254.08% to -$12.0 million in 2021, then surged by 218.72% to $14.2 million in 2022.
- The last three Other financing activities figures came in at $14.2 million (Q1 2022), -$12.0 million (Q3 2021), and $20.0 million (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 14.24 Mn |
| Mar 31, 2022 | 14.24 Mn |
| Sep 30, 2021 | -11.99 Mn |
| Sep 30, 2021 | -11.99 Mn |
| Mar 31, 2021 | 20.03 Mn |
| Mar 31, 2021 | 20.03 Mn |
| Sep 30, 2020 | 7.78 Mn |
| Sep 30, 2020 | 7.78 Mn |
| Mar 31, 2020 | 14.62 Mn |
| Mar 31, 2020 | 14.62 Mn |
| Sep 30, 2019 | 3.11 Mn |
| Sep 30, 2019 | 3.11 Mn |
| Jun 30, 2019 | 15.19 Mn |
| Jun 30, 2019 | 15.19 Mn |
| Mar 31, 2019 | 15.48 Mn |
| Mar 31, 2019 | 15.48 Mn |
| Jun 30, 2018 | 15.48 Mn |
| Jun 30, 2018 | 15.48 Mn |
| Mar 31, 2018 | 2.58 Mn |
| Mar 31, 2018 | 2.58 Mn |